NDC 60986-1009

Sabal Serrulatum

Sabal Serulatum, Lycopodium Clavatum, Pareira Brava

Sabal Serrulatum is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Marco Pharma International Llc.. The primary component is Saw Palmetto; Lycopodium Clavatum Spore; Chondrodendron Tomentosum Root.

Product ID60986-1009_6670bb33-d3cb-42bb-aa45-6d06a2c7681e
NDC60986-1009
Product TypeHuman Otc Drug
Proprietary NameSabal Serrulatum
Generic NameSabal Serulatum, Lycopodium Clavatum, Pareira Brava
Dosage FormLiquid
Route of AdministrationORAL
Marketing Start Date1992-03-01
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameMarco Pharma International LLC.
Substance NameSAW PALMETTO; LYCOPODIUM CLAVATUM SPORE; CHONDRODENDRON TOMENTOSUM ROOT
Active Ingredient Strength1 [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 60986-1009-3

50 mL in 1 BOTTLE, GLASS (60986-1009-3)
Marketing Start Date2018-02-28
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 60986-1009-4 [60986100904]

Sabal Serrulatum LIQUID
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-02-28
Inactivation Date2020-01-31

NDC 60986-1009-3 [60986100903]

Sabal Serrulatum LIQUID
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-02-28
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
SAW PALMETTO1 [hp_X]/100mL

OpenFDA Data

SPL SET ID:158394db-fc09-4a17-a55b-12329d972c2a
Manufacturer
UNII

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.